Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Anti-MUC1-monoclonal-antibody-AR20-5 in pancreatic cancer patients

Next Previous
Trial Profile

Study of Anti-MUC1-monoclonal-antibody-AR20-5 in pancreatic cancer patients

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anti-MUC1 monoclonal antibody AR20-5 (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 21 Aug 2023 According to a CanariaBio media release, the company is planning to initiate clinical trials to assess the safety and efficacy of MAb-AR20.5 in patients with pancreatic cancer.
    • 21 Aug 2023 According to a CanariaBio media release, the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its investigational drug product, MAb-AR20.5 for pancreatic cancer.
    • 14 Nov 2016 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top